摘要:
On emploie la recombinaison homologue afin d'inactiver des gènes, notamment des gènes associés à des antigènes de complexes d'hystocompatibilité majeure (CHM). On a notamment inactivé le gène de beta2-microglobuline afin de réduire ou d'éliminer les antigènes de CHM de la classe A. On peut utiliser les cellules ainsi obtenues en tant que donneuses universelles. De plus, on peut modifier des cellules souche embryonnaires par recombinaison homologue, afin de les utiliser dans la production d'hôtes mammifères chimériques ou transgéniques.
摘要:
Homologous recombination is employed to inactivate genes, particularly genes associated with MHC antigens. Particularly, the β2-microglobulin gene is inactivated for reducing or eliminating the expression of functional Class I MHC antigens. The resulting cells may be used as universal donor cells. In addition, embryonic stem cells may be modified by homologous recombination for use in producing chimeric or transgenic mammalian hosts, which may be used as source of universal donor organs, or as models for drug and transplantation therapies. Methods for homologous recombination in non-transformed mammalian somatic cells are also described.
摘要:
Homologous recombination is employed to inactivate genes, particularly genes associated with MHC antigenes. Particularly, the β2-microglobulin gene is inactivated for reducing or eliminating Class I MHC antigenes. The resulting cells may be used as universal donors. In addition, embryonic stem cells may be modified by homologous recombination for use in producing chimeric or transgenic mammalian hosts.
摘要:
Homologous recombination is employed to inactivate genes, particularly genes associated with MHC antigens. Particularly, the β2-microglobulin gene is inactivated for reducing or eliminating the expression of functional Class I MHC antigens. The resulting cells may be used as universal donor cells. In addition, embryonic stem cells may be modified by homologous recombination for use in producing chimeric or transgenic mammalian hosts, which may be used as source of universal donor organs, or as models for drug and transplantation therapies. Methods for homologous recombination in non-transformed mammalian somatic cells are also described.